Epoch HealthMelanoma: The Aggressive Skin Cancer That Can Spread Quickly–Here Are the Warning Signs

Melanoma accounts for only 1% of skin cancers but leads skin disease mortality, with a 97% five-year survival rate at early stages collapsing to 30% at stage 4. Patients increasingly arrive with misinformation from consumer health sources, requiring oncologists to reframe expectations around screening, risk factors, and emerging therapies.

🩺 Patient Counseling Points

• Tanning bed use carries nearly a threefold increased melanoma risk and tattoos a 29% higher risk, both modifiable exposures requiring direct counseling at intake
• Stage 3 and 4 treatment now centers on immunotherapy and targeted therapy, with BRAF/MEK inhibitor combinations and combination checkpoint blockade (nivolumab/ipilimumab) as standard systemic options
• Lifileucel tumor-derived autologous T-cell therapy offers a viable pathway for stage 4 patients after prior immunotherapy failure
• Emerging data on targeted amino acid deprivation achieved complete remission in one phase I advanced melanoma patient resistant to immunotherapy, warranting patient awareness without overpromising

🎯 Patient Care Applications

• Refer newly diagnosed melanoma patients for sentinel lymph node biopsy based on Breslow depth at time of primary excision
• Counsel immunotherapy candidates that high-fiber diets may enhance checkpoint inhibitor response via gut microbiome support
• Screen patients with CLL, prior breast cancer, or thyroid cancer for elevated secondary melanoma risk at each visit
• Document family history of melanoma in patients under 45 and refer for genetic testing when three or more first-degree relatives are affected

More on Skin Cancer